http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03112936-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 1990-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d2888d527464cafd671715df97f2dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1869942ca436149501d076f600bd1f5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_221768aa5f11252f6c04ea9687c295b4 |
| publicationDate | 1991-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H03112936-A |
| titleOfInvention | Controlled release carbonic anhydrase-inhibiting factor-containing pharmaceutical composition comprising capsule filled with spherical granule in oral administration unit form |
| abstract | PURPOSE: To obtain a controlled release pharmaceutical composition in an oral unit administration form by filling a capsule with active spherical granules comprising an active carbonic anhydrase-inhibiting factor medicine, a diluent for forming a matrix in which the medicine is dispersed, and arbitrarily a vehicle. n CONSTITUTION: This controlled release pharmaceutical composition comprises an active carbonic anhydrase-inhibiting factor medicine (e.g. methazolamide), a diluent solid at the ordinary temperature and suitable for forming medicine- dispersed matrix, preferably fine crystalline cellulose, and, if necessary, a pharmaceutically acceptable vehicle. The components are mixed by a mixer. The mixture is granulated in the presence of a granulating liquid, and the granules are extruded and subsequently sphered to form the spherical granules capable of being compressed. The spherical granules are dried, filled into a capsule having a hard or soft outer shell in the therapeutically effective number. If necessary, the capsule is sealed. n COPYRIGHT: (C)1991,JPO |
| priorityDate | 1989-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4100 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502129 |
Total number of triples: 27.